Facile Synthesis of [1,2,4]Triazolo[4,3-a]pyrazin-3-amines via Oxidative Cyclization of 1-(Pyrazin-2-yl)guanidine Derivatives

Abstract

In this study, we applied a novel, mild, and convenient synthetic method involving the oxidative cyclization of 1-(pyrazin-2-yl)guanidine derivatives to produce [1,2,4]triazolo[4,3-a]pyrazin-3-amines. We optimized the reaction procedure to easily obtain 5-chloro-[1,2,4]triazolo[4,3-a]pyrazin-3-amine. Various types of halogenated pyrazines can successfully undergo this process. We synthesized a series of 1-(pyrazin-2-yl)guanidines and [1,2,4]triazolo[4,3-a]pyrazin-3-amines, and then elucidated their structures based on their ¹H-NMR, ¹³C-NMR, ESI-HRMS, and nuclear Overhauser effect spectra.

Keywords

Triazolopyrazines / [1,2,4]Triazolo[4,3-a]pyrazin-3-amines / 1-(Pyrazin-2-yl)guanidines / Cyclization / Synthesis

References

[1] He T, Yu L, Zhang L, et al. Direct C2-alkylation of azoles with alcohols and ethers through dehydrogenative cross-coupling under metal-free conditions. Org Lett, 2011, 13(19): 5016-5019.

[2] Bober AE, Proto JT, Brummond KM. Intramolecular didehydro-diels-alder reaction for the synthesis of benzo- and dihydrobenzo-fused heterocycles. Org Lett, 2017, 19(7): 1500-1503.

[3] Zhang HM, Zhang HJ, Tian YS, et al. Synthesis and anticonvulsant activity evaluation of phthalazine and heterocyclic derivatives. Chin J Org Chem, 2017, 37(9): 2322-2327. in Chinese)

[4] Kelley JL, Linn JA, Bankston DD, et al. 8-Amino-3-benzyl-1,2,4-triazolo[4,3-a] pyrazines. Synthesis and anticonvulsant activity. J Med Chem, 1995, 38(18): 3676-3679.

[5] Majumdar KC, Ray K. Synthesis of 1,2,3-triazole-fused heterocycles via intramolecular azide-alkyne cycloaddition reactions. Synthesis, 2011, 2011(23): 3767-3783.

[6] Davies SG, Fletcher AM, Lv L, et al. Asymmetric synthesis of (−)-(R)-sitagliptin. Tetrahedron Lett, 2012, 53(24): 3052-3055.

[7] Mal S, Prathap KJ, Smith SC, et al. Facile one pot synthesis of 8-chloro-[1,2,4]triazolo [4,3-a]pyrazines via oxidative cyclisation using chloramine T. Tetrahedron Lett, 2015, 56(22): 2896-2901.

[8] González SM, Hernández AI, Álvarez RM, et al. Identification of novel PI3K inhibitors through a scaffold hopping strategy. Bioorg Med Chem Lett, 2017, 27(21): 4794-4799.

[9] Yang Y, Zhang Y, Yang LY, et al. Discovery of imidazopyridine derivatives as novel c-Met kinase inhibitors: synthesis, SAR study, and biological activity. Bioorg Chem, 2017, 70: 126-132.

[10] Ye L, Wu J, Yang J, et al. Design, synthesis and molecular docking analysis of some novel 7-[(quinolin-6-yl) methyl] purines as potential c-Met inhibitors. Med Chem Res, 2015, 24(8): 3327-3333.

[11] Bradbury RH, Major JS, Oldham AA, et al. 1, 2, 4-Triazolo[4, 3-a]pyrazine derivatives with human renin inhibitory activity. 2. Synthesis, biological properties and molecular modeling of hydroxyethylene isostere derivatives. J Med Chem, 1990, 33(9): 2335-2342.

[12] Bradbury RH, Rivett JE. 1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 3.1 Synthesis and biological properties of aminodeoxystatine and difluorostatone derivatives. J Med Chem, 1991, 34(1): 151-157.

[13] Yao G, Haque S, Sha L, et al. Synthesis of alkyne derivatives of a novel triazolopyrazine as A(2A) adenosine receptor antagonists. Bioorg Med Chem Lett, 2005, 15(3): 511-515.

[14] Bacilieri M, Ciancetta A, Paoletta S, et al. Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists. J Chem Inf Model, 2013, 53(7): 1620-1637.

[15] Falsini M, Squarcialupi L, Catarzi D, et al. The 1,2,4-triazolo[4,3-a]pyrazin-3-one as a versatile scaffold for the design of potent adenosine human receptor antagonists. Structural investigations to target the A_2A receptor subtype. J Med Chem, 2017, 60(3): 5772-5790.

[16] Yang YS, Cao XF, Li Z et al (2014) Novel triazole antifungal compound, pharmaceutical composition and preparation method and application thereof: CN 103965194 A (in Chinese)

[17] Luo W, Ding CZ, Huang ZG et al (2017) Anti-pulmonary tuberculosis nitroimidazole derivative: WO 2016/119706 A1

[18] Cao X, Sun Z, Cao Y, et al. Design, synthesis, and structure-activity relationship studies of novel fused heterocycles-linked triazoles with good activity and water solubility. J Med Chem, 2014, 57(9): 3687-3706.

[19] Gideon S (2016) Bicyclic azaheterocyclic compounds as NR2B NMDA receptor antagonists: WO 2016/100349 A2

[20] Westlund N (2011) Substituted triazolo-pyrazine compounds: US 2011/0160215 A1

[21] Mallett SE, Rose FL. s-Triazolopyrazines. J Chem Soc C, 1966, 0: 2038-2043.

[22] Comas H, Bernardinelli G, Swinnen D. A straightforward, one-pot protocol for the synthesis of fused 3-aminotriazoles. J Org Chem, 2009, 74(15): 5553-5558.

[23] Sun N, Li B, Shao J, et al. A general and facile one-pot process of isothiocyanates from amines under aqueous conditions. Beilstein J Org Chem, 2012, 8: 61-70.

[24] Munch H, Hansen JS, Pittelkow M, et al. A new efficient synthesis of isothiocyanates from amines using di-tert-butyl dicarbonate. Tetrahedron Lett, 2008, 49(19): 3117-3119.

[25] Ishimoto K, Nagata T, Murabayashi M, et al. Oxidative cyclization of 1-(pyridin-2-yl)guanidine derivatives: a synthesis of [1,2,4]triazolo[1,5-a]pyridin-2-amines and an unexpected synthesis of [1,2,4]triazolo[4,3-a]pyridin-3-amines. Tetrahedron, 2015, 71(3): 407-418.

[26] Kai S, Carl D, Guenter H et al (2013) Triazolopyrazine derivatives: WO 2013/131609 A1

[27] Yagupolskii LM, Shelyazhenko SV, Maletina II, et al. The aza curtius rearrangement. Eur J Org Chem, 2001, 2001(7): 1225-1233.